Form4insider filings, from the source

SEC Form 4 · accession 0001219036-15-000004

MYRIAD GENETICS INC · MYGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jerry S Lanchbury
Officer — Chief Scientific Officer
Period of report
Sep 15, 2015
Accepted (ET)
Sep 17, 2015 · 6:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899923

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockSep 15, 2015M50,000$16.53A127,634D
Common StockSep 15, 2015S50,000$39.8791D77,634D
Common StockSep 15, 2015M10,000$18.06A87,634D
Common StockSep 15, 2015S10,000$39.8791D77,634D
Common StockSep 17, 2015F6,897$41.39D70,737D
Common StockSep 17, 2015M270$16.53A71,007D
Common StockSep 17, 2015S270$41.39D70,737D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (right to buy)F3$16.53Sep 15, 2015M50,000D—Sep 15, 2020Common Stock50,00019,999D
Non-Qualified Stock Option (right to buy)F3$16.53Sep 17, 2015M270D—Sep 15, 2020Common Stock27019,729D
Non-Qualified Stock Option (right to buy)F3$18.06Sep 15, 2015M10,000D—Sep 26, 2017Common Stock10,0000D

Explanation of responses